Cargando…
Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia
BACKGROUND: Off-patent pharmaceuticals (OPPs) hold vital importance in meeting public health objectives, especially in developing countries where resources are limited. OPPs are comprised of off-patent originals, branded generics and unbranded generics; nonetheless, these products are not identical...
Autores principales: | Inotai, Andras, Brixner, Diana, Maniadakis, Nikos, Dwiprahasto, Iwan, Kristin, Erna, Prabowo, Agus, Yasmina, Alfi, Priohutomo, Sigit, Németh, Bertalan, Wijaya, Kalman, Kalo, Zoltan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310978/ https://www.ncbi.nlm.nih.gov/pubmed/30594250 http://dx.doi.org/10.1186/s12913-018-3805-3 |
Ejemplares similares
-
Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand
por: Holtorf, Anke-Peggy, et al.
Publicado: (2021) -
A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt
por: Elezbawy, Baher, et al.
Publicado: (2022) -
A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt
por: Elezbawy, Baher, et al.
Publicado: (2022) -
Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs
por: Schey, C., et al.
Publicado: (2017) -
Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs
por: Kolasa, Katarzyna, et al.
Publicado: (2016)